Oxford Endovascular: Funding, Investors & Team (Sep 2026)
Oxford Endovascular is creating a unique therapy for brain aneurysms by utilizing a specialized metal alloy with shape memory. This technology is inserted into a catheter during surgery, then expanded into a small tube mesh in the brain to divert blood flow away from the aneurysm and promote healing.
Oxford Endovascular has raised $10.2M across 1 funding round on record, the most recent a Series A of $10.2M announced in May 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oxford Endovascular Company Profile and Key Stats
Latest funding round on record: May 2024.
Oxford Endovascular Funding Rounds
Oxford Endovascular Founders and Leadership Team
Contact details for the Oxford Endovascular team: 1 of 1 has an email address on file.
Start 14-day free trial →Oxford Endovascular Funding Compared to Other Biotechnology Startups
Oxford Endovascular's latest round of $10.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oxford Endovascular in Biotechnology and Oxford
Companies Similar to Oxford Endovascular
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Oxford Endovascular Funding FAQs
What does Oxford Endovascular do?
Oxford Endovascular is creating a unique therapy for brain aneurysms by utilizing a specialized metal alloy with shape memory. This technology is inserted into a catheter during surgery, then expanded into a small tube mesh in the brain to divert blood flow away from the aneurysm and promote healing.
How much funding has Oxford Endovascular raised?
Oxford Endovascular has raised $10.2M across 1 round on record. The most recent is a Series A of $10.2M announced in May 2024.
When did Oxford Endovascular last raise funding?
Oxford Endovascular's most recent funding round on record is a Series A of $10.2M, announced in May 2024.
Who founded Oxford Endovascular?
FundedIQ lists Mike Karim (Founder) at Oxford Endovascular.
Where is Oxford Endovascular headquartered?
Oxford Endovascular is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Oxford Endovascular have?
Oxford Endovascular is in the 1-10 employee band.
How does Oxford Endovascular's funding compare to other Biotechnology startups?
Oxford Endovascular's latest round of $10.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Oxford Endovascular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oxford Endovascular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.